MODELI NG CLINICAL AND ECONOMIC OUTCOMES OF TESTING FOR LTBI WITH T-SPOT.TB IN IMMUNOCOMPROMISED CHILDREN
weakening of immune status under the influence of some diseases or types of treatment could result in the activation of the present latent tuberculosis infection (LTBI). Recently it was suggested to use the immunoenzymometric interferon-gamma tests, T-SPOT.TB among them, but their costs are substant...
Saved in:
Main Authors: | V. I. Ignatyeva, M. V. Avxentyeva, V. V. Omelyanovsky, G. R. Khachatryan |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2015-03-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/73 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Screening for tuberculosis of patients with HIV-infection. New possibilities
by: E. A. Borodulina, et al.
Published: (2022-05-01) -
Clinical characteristics and potential indicators for definite diagnosis of tuberculous pleural effusion
by: Xuemei Yang, et al.
Published: (2019-12-01) -
Characteristics of subclinical pulmonary tuberculosis compared to active pulmonary tuberculosis: A retrospective cohort study
by: Aiping Zhang, et al.
Published: (2025-08-01) -
Comparison of QFT-IT and QFT-Plus for Detecting Latent Tuberculosis in HIV-Infected Iranian Patients
by: Zahra Abtahian, et al.
Published: (2025-07-01) -
Cycloferon in the Treatment of Immunocompromised Patients with Allergic Rhinitis
by: N. S. Tataurshchikova
Published: (2020-05-01)